ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Post-Doctoral Scientist – Delivery, Devices & Connected Solutions (DDCS) Inhaled Drug Formulation & Aerosol Science at Eli Lilly and Company - ApplyBlast

Post-Doctoral Scientist – Delivery, Devices & Connected Solutions (DDCS) Inhaled Drug Formulation & Aerosol Science

Eli Lilly and Company

4 months ago

4.0 on Glassdoor

USA

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Postdoctoral Scientist at Eli Lilly develops predictive computational models of aerosol deposition to advance inhalation therapies. This role involves designing in vitro experiments, validating computational fluid dynamics and pharmacokinetic models, and collaborating with multidisciplinary teams to optimize device performance and formulation design. The position focuses on translating research findings into actionable insights for preclinical-to-clinical strategies in pulmonary and nasal delivery systems.

Responsibilities

Design and execute in vitro aerosol characterization experiments
Develop and validate computational fluid dynamics models
Integrate experimental data with in-silico deposition predictions
Apply uncertainty quantification to computational models
Collaborate with formulation scientists and device engineers

Skills

Qualifications

Ph.D. in Mechanical EngineeringPh.D. in Chemical EngineeringPh.D. in Biomedical EngineeringPh.D. in Aerosol Science

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.